Pelvic mass, ascites, hydrothorax: a malignant or benign condition? Meigs syndrome with high levels of CA 125

被引:19
作者
Stabile, Guglielmo [1 ]
Zinicola, Giulia [2 ]
Romano, Federico [1 ]
Lagana, Antonio Simone [3 ]
Dal Pozzolo, Chiara [2 ]
Ricci, Giuseppe [1 ,2 ]
机构
[1] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy
[2] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
[3] Univ Insubria, Filippo Del Ponte Hosp, Dept Obstet & Gynecol, Varese, Italy
来源
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY | 2021年 / 20卷 / 02期
关键词
Meigs syndrome; CA; 125; pelvic mass; ascites; hydrothorax; fibrothecoma; ovarian cancer; LOGISTIC-REGRESSION MODELS; OVARIAN; SURGERY;
D O I
10.5114/pm.2021.106100
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Abdominal-pelvic mass, ascites and pleural effusion are suggestive of malignant metastatic ovarian cancer. This triad is also present in a rare benign condition called Meigs syndrome. Rarely this condition is associated with an increased CA 125 level. Case report: A 62-year-old woman with a history of abdominal pain underwent an ultrasound (US) examination and a chest X-ray. The imaging revealed the presence of a large pelvic mass and ascites with a monolateral pleural effusion and a high level of the tumor marker CA 125. The patient underwent a total abdominal hysterectomy, salpingoophorectomy, removal of the pelvic mass, pelvic lymphadenectomy and peritoneal biopsies. The histology showed an ovarian fibrothecoma. Discussion: The US analysis according to international ovarian tumor analysis simple rules revealed "inconclusive results"; the logistic regression model LR2 and Adnex suggested a high risk of malignancy. The presence of ascites and the size of the lesion associated with a high level of CA 125 affected the correct assessment of the risk of malignancy, exposing the patient to overtreatment Conclusions: Meigs syndrome is characterized by the resolution of symptoms after surgical removal of the pelvic mass. However, it mimics the clinical picture of a malignant metastatic ovarian cancer. Clinicians have to exclude ovarian cancer and recognize the syndrome to reduce inappropriate procedures.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 26 条
[1]   Meigs' syndrome with elevated CA125: case report and review of the literature [J].
Abad, A ;
Cazorla, E ;
Ruiz, F ;
Aznar, I ;
Asins, E ;
Llixiona, J .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 82 (01) :97-99
[2]   Pleural effusion and a pelvic mass [J].
Agranoff, D ;
May, D ;
Jameson, C ;
Knowles, GK .
POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (871) :265-267
[3]  
Bognoni V, 1999, Minerva Ginecol, V51, P509
[4]  
Cisse C-T, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P251
[5]   Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses [J].
Di Legge, A. ;
Testa, A. C. ;
Ameye, L. ;
Van Calster, B. ;
Lissoni, A. A. ;
Leone, F. P. G. ;
Savelli, L. ;
Franchi, D. ;
Czekierdowski, A. ;
Trio, D. ;
Van Holsbeke, C. ;
Ferrazzi, E. ;
Scambia, G. ;
Timmerman, D. ;
Valentin, L. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 40 (03) :345-354
[6]   Fertility sparing surgery in early stage epithelial ovarian cancer [J].
Ditto, Antonino ;
Martinelli, Fabio ;
Lorusso, Domenica ;
Haeusler, Edward ;
Carcangiu, Marialuisa ;
Raspagliesi, Francesco .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2014, 25 (04) :320-327
[7]   Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population [J].
Froyman, Wouter ;
Wynants, Laure ;
Landolfo, Chiara ;
Bourne, Tom ;
Valentin, Lil ;
Testa, Antonia ;
Sladkevicius, Povilas ;
Franchi, Dorella ;
Fischerova, Daniela ;
Savelli, Luca ;
Van Calster, Ben ;
Timmerman, Dirk .
DIAGNOSTICS, 2017, 7 (02)
[8]  
JACOBS I, 1989, HUM REPROD, V4, P1
[9]   Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies [J].
Kaijser, J. ;
Bourne, T. ;
Valentin, L. ;
Sayasneh, A. ;
Van Holsbeke, C. ;
Vergote, I. ;
Testa, A. C. ;
Franchi, D. ;
Van Calster, B. ;
Timmerman, D. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (01) :9-20
[10]   USE OF CA 125 MONOCLONAL-ANTIBODY TO MONITOR PATIENTS WITH OVARIAN-CANCER [J].
KUDLACEK, S ;
SCHIEDER, K ;
KOLBL, H ;
NEUNTEUFEL, W ;
NOWOTNY, C ;
BREITENECKER, G ;
BIEGELMAYER, G ;
VETTERLEIN, M ;
FURLINGER, B ;
MICKSCHE, M .
GYNECOLOGIC ONCOLOGY, 1989, 35 (03) :323-329